Analysis of mutant SOD1 electrophoretic mobility by blue native gel electrophoresis; evidence for soluble multimeric assemblies

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Brown, Hilda H ^a   Borchelt, David R ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; MUTANT PROTEIN; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; CELL LINE; ELECTROPHORESIS; GENETICS; HALF LIFE TIME; HEK293 CELL LINE; HUMAN; MOLECULAR WEIGHT; MUTATION; PROCEDURES;

AMYOTROPHIC LATERAL SCLEROSIS; CELL LINE; ELECTROPHORESIS; HALF-LIFE; HEK293 CELLS; HUMANS; MOLECULAR WEIGHT; MUTANT PROTEINS; MUTATION; SUPEROXIDE DISMUTASE;

EID: 84905974216     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104583     Document Type: Article

References (49)

1. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. (1993) Mutations in cu/zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62. (Pubitemid 23087289)
2. Parge HE, Hallewell RA, Tainer JA (1992) Atomic structures of wild-type and thermostable mutant recombinant human cu,zn superoxide dismutase. Proc Natl Acad Sci U S A 89: 6109-6113.
3. Ogihara NL, Parge HE, Hart PJ, Weiss MS, Goto JJ, et al. (1996) Unusual trigonal-planar copper configuration revealed in the atomic structure of yeast copper-zinc superoxide dismutase. Biochemistry 35: 2316-2321. (Pubitemid 26071664)
4. Fridovich I (1974) Superoxide dismutases. Adv Enzymol Relat Areas Mol Biol 41: 35-97.
5. Rodriguez JA, Shaw BF, Durazo A, Sohn SH, Doucette PA, et al. (2005) Destabilization of apoprotein is insufficient to explain cu,zn-superoxide dismutase-linked ALS pathogenesis. Proc Natl Acad Sci U S A 102: 10516-10521. (Pubitemid 41061586)
6. Bruijn LI, Miller TM, Cleveland DW (2004) Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27: 723-749. (Pubitemid 39050419)
7. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, et al. (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci U S A 91: 8292-8296. (Pubitemid 24253933)
8. Nishida CR, Gralla EB, Valentine JS (1994) Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 91: 9906-9910. (Pubitemid 24311917)
9. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, et al. (1996) Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271: 515-518. (Pubitemid 26044472)
10. Hayward LJ, Rodriguez JA, Kim JW, Tiwari A, Goto JJ, et al. (2002) Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J Biol Chem 277: 15923-15931. (Pubitemid 34967873)
11. Ratovitski T, Corson LB, Strain J, Wong P, Cleveland DW, et al. (1999) Variation in the biochemical/biophysical properties of mutant superoxide dismutase 1 enzymes and the rate of disease progression in familial amyotrophic lateral sclerosis kindreds. Hum Mol Genet 8: 1451-1460. (Pubitemid 29374078)
12. Jonsson PA, Ernhill K, Andersen PM, Bergemalm D, Brannstrom T, et al. (2004) Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain 127: 73-88. (Pubitemid 38055347)
13. Wang J, Xu G, Li H, Gonzales V, Fromholt D, et al. (2005) Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: {Alpha}B-crystallin modulates aggregation. Hum Mol Genet 14: 2335-2347. (Pubitemid 41417996)
14. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al. (1994) Motor neuron degeneration in mice that express a human cu,zn superoxide dismutase mutation. Science 264: 1772-1775. (Pubitemid 24227760)
15. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, et al. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14: 1105-1116. 0896-6273(95)90259-7.
16. Jonsson PA, Graffmo KS, Brannstrom T, Nilsson P, Andersen PM, et al. (2006) Motor neuron disease in mice expressing the wild type-like D90A mutant superoxide dismutase-1. J Neuropathol Exp Neurol 65: 1126-1136. (Pubitemid 44885937)
17. Johnston JA, Dalton MJ, Gurney ME, Kopito RR (2000) Formation of high molecular weight complexes of mutant cu, zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 97: 12571-12576.
18. Shinder GA, Lacourse MC, Minotti S, Durham HD (2001) Mutant cu/zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J Biol Chem 276: 12791-12796.
19. Wang J, Xu G, Gonzales V, Coonfield M, Fromholt D, et al. (2002) Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol Dis 10: 128-138. (Pubitemid 34775466)
20. Prudencio M, Hart PJ, Borchelt DR, Andersen PM (2009) Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease. Hum Mol Genet 18: 3217-3226.
21. Wang J, Xu G, Borchelt DR (2002) High molecular weight complexes of mutant superoxide dismutase 1: Age- dependent and tissue-specific accumulation. Neurobiol Dis 9: 139-148. (Pubitemid 34261210)
22. Wang J, Farr GW, Zeiss CJ, Rodriguez-Gil DJ, Wilson JH, et al. (2009) Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc Natl Acad Sci U S A 106: 1392-1397.
23. Zetterstrom P, Stewart HG, Bergemalm D, Jonsson PA, Graffmo KS, et al. (2007) Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proc Natl Acad Sci U S A 104: 14157-14162. (Pubitemid 350003351)
24. Zetterstrom P, Graffmo KS, Andersen PM, Brannstrom T, Marklund SL (2013) Composition of soluble misfolded superoxide dismutase-1 in murine models of amyotrophic lateral sclerosis. Neuromolecular Med 15: 147-158.
25. Schagger H, von Jagow G (1991) Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199: 223-231.
26. Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, et al. (2003) Copper-binding-site-null SOD1 causes ALS in transgenic mice: Aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet 12: 2753-2764. (Pubitemid 37407112)
27. Karch CM, Borchelt DR (2008) A limited role for disulfide cross-linking in the aggregation of mutant SOD1 linked to familial amyotrophic lateral sclerosis. J Biol Chem 283: 13528-13537.
28. Karch CM, Borchelt DR (2010) Aggregation modulating elements in mutant human superoxide dismutase 1. Arch Biochem Biophys 503: 175-182.
29. Karch CM, Borchelt DR (2010) An examination of alpha B-crystallin as a modifier of SOD1 aggregate pathology and toxicity in models of familial amyotrophic lateral sclerosis. J Neurochem 113: 1092-1100.
30. Prudencio M, Borchelt DR (2011) Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states. Mol Neurodegener 6: 77.
31. Ayers J, Lelie H, Workman A, Prudencio M, Brown H, et al. (2014) Distinctive features of the D101N and D101G variants of superoxide dismutase 1; two mutations that produce rapidly progressing motor neuron disease. J Neurochem 128: 305-314.
32. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, et al. (1997) ALSlinked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18: 327-338. (Pubitemid 27111114)
33. Urushitani M, Ezzi SA, Julien JP (2007) Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 104: 2495-2500. (Pubitemid 46391424)
34. Rakhit R, Robertson J, Vande VC, Horne P, Ruth DM, et al. (2007) An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS. Nat Med 13: 754-759. (Pubitemid 46889748)
35. Mizushima S, Nagata S (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18: 5322. (Pubitemid 20270119)
36. Shi Y, Mowery RA, Ashley J, Hentz M, Ramirez AJ, et al. (2012) Abnormal SDS-PAGE migration of cytosolic proteins can identify domains and mechanisms that control surfactant binding. Protein Sci 21: 1197-1209.
37. Roberts BL, Patel K, Brown HH, Borchelt DR (2012) Role of disulfide cross-linking of mutant SOD1 in the formation of inclusion-body-like structures. PLoS ONE 7: e47838.
38. Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR (2009) Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci U S A 106: 7774-7779.
39. Zhang F, Zhu H (2006) Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death. Biochim Biophys Acta 1760: 404-414.
40. Okado-Matsumoto A, Fridovich I (2002) Amyotrophic lateral sclerosis: A proposed mechanism. Proc Natl Acad Sci U S A 99: 9010-9014. (Pubitemid 34693674)
41. Choi JS, Cho S, Park SG, Park BC, Lee DH (2004) Co-chaperone CHIP associates with mutant cu/zn-superoxide dismutase proteins linked to familial amyotrophic lateral sclerosis and promotes their degradation by proteasomes. Biochem Biophys Res Commun 321: 574-583. (Pubitemid 39127405)
42. Watanabe Y, Morita E, Fukada Y, Doi K, Yasui K, et al. (2008) Adherent monomer-misfolded SOD1. PLoS One 3: e3497.
43. Zetterstrom P, Graffmo KS, Andersen PM, Brannstrom T, Marklund SL (2011) Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice. J Biol Chem 286: 20130-20136.
44. Zhang F, Strom AL, Fukada K, Lee S, Hayward LJ, et al. (2007) Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex. J Biol Chem 282: 16691-16699. (Pubitemid 47100405)
45. Jain MR, Ge WW, Elkabes S, Li H (2008) Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models. Proteomics Clin Appl 2: 670-684. (Pubitemid 351772023)
46. Ayers JI, Xu G, Pletnikova O, Troncoso JC, Hart PJ, et al. (2014) Conformatonal specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases. Acta neuropathologica communications 2: 55.
47. Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, et al. (2010) Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci 13: 1396-1403.
48. Seetharaman SV, Winkler DD, Taylor AB, Cao X, Whitson LJ, et al. (2010) Disrupted zinc-binding sites in structures of pathogenic SOD1 variants D124V and H80R. Biochemistry 49: 5714-5725.
49. Elam JS, Taylor AB, Strange R, Antonyuk S, Doucette PA, et al. (2003) Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nat Struct Biol 10: 461-467. (Pubitemid 36637644) Stroke